Raffles Associates’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.89M | Sell |
|
|||||
|
2025
Q1 | $2.55M | Buy |
|
|||||
|
2024
Q4 | $2.76M | Buy |
|
|||||
|
2024
Q3 | $4.08M | Buy |
|
|||||
|
2024
Q2 | $4.35M | Buy |
|
|||||
|
2024
Q1 | $4.75M | Buy |
|
|||||
|
2023
Q4 | $2.32M | Buy |
|
|||||
|
2023
Q3 | $1.87M | Sell |
|
|||||
|
2023
Q2 | $2.25M | Buy |
|
|||||
|
2023
Q1 | $2.31M | Hold |
|
|||||
|
2022
Q4 | $1.8M | Sell |
|
|||||
|
2022
Q3 | $2.35M | Buy |
|
|||||
|
2022
Q2 | $3.05M | Buy |
|
|||||
|
2022
Q1 | $2.01M | Buy |
|
|||||
|
2021
Q4 | $1.33M | Buy |
|
|||||
|
2021
Q3 | $236K | Buy |
|
|||||
|
2021
Q2 | $124K | Hold |
|
|||||
|
2021
Q1 | $102K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $93K | Buy |
|